Search

Your search keyword '"Elisa Gobbini"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Elisa Gobbini" Remove constraint Author: "Elisa Gobbini"
47 results on '"Elisa Gobbini"'

Search Results

1. Dpb4 promotes resection of DNA double-strand breaks and checkpoint activation by acting in two different protein complexes

2. Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases

3. Sae2 and Rif2 regulate MRX endonuclease activity at DNA double-strand breaks in opposite manners

4. The 9-1-1 Complex Controls Mre11 Nuclease and Checkpoint Activation during Short-Range Resection of DNA Double-Strand Breaks

5. Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine

6. Local unwinding of double-strand DNA ends by the MRX complex promotes Exo1 processing activity

7. Tel1 and Rif2 Regulate MRX Functions in End-Tethering and Repair of DNA Double-Strand Breaks.

8. Sae2 Function at DNA Double-Strand Breaks Is Bypassed by Dampening Tel1 or Rad53 Activity.

9. Expert consensus on perioperative treatment for non-small cell lung cancer

10. Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review

11. Immune checkpoint inhibitors and hospitalization at home in France

12. Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis

13. How do cells sense DNA lesions?

14. Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences

15. Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods

16. Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer

17. Resection of a DNA Double-Strand Break by Alkaline Gel Electrophoresis and Southern Blotting

18. The 9-1-1 Complex Controls Mre11 Nuclease and Checkpoint Activation during Short-Range Resection of DNA Double-Strand Breaks

19. Literature meta-analysis about the efficacy of re-challenge with PD-1 and PD-L1 inhibitors in cancer patients

20. Literature meta-analysis about the efficacy of anti-programmed death protein 1 and anti-programmed death ligand 1 re-challenge in cancer patients

21. Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study

22. Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients

23. Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

24. Current opinions in immune checkpoint inhibitors rechallenge in solid cancers

25. Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional Analyses

26. Coupling end resection with the checkpoint response at DNA double-strand breaks

27. Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer

28. IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer

29. The <scp>MRX</scp> complex regulates Exo1 resection activity by altering <scp>DNA</scp> end structure

30. Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?

31. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

32. MA08.02 Durvalumab Impact in the Treatment Strategy of Stage III Non-Small Cell Lung Cancer (NSCLC): An EORTC Young Investigator Lung Cancer Group Survey

33. P1.14-26 ALK Fusion Variant Detection by Targeted RNA-Seq in TKIs Treated ALK-Positive Lung Adenocarcinoma

34. Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

35. Escape of Sgs1 from Rad9 inhibition reduces the requirement for Sae2 and functional <scp>MRX</scp> in <scp>DNA</scp> end resection

36. Structurally distinct Mre11 domains mediate MRX functions in resection, end-tethering and DNA damage resistance

37. Rechallenge avec les inhibiteurs des points de contrôle immunitaires (ICPis) : issues cliniques dans une cohorte nationale française de patients atteints d’un cancer bronchique non à petites cellules (CBNPC)

38. MA26.02 Upfront or Sequential Strategy for New Generation Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Italian Retrospective Study

39. Functions and regulation of the MRX complex at DNA double-strand breaks

40. Sae2 Function at DNA Double-Strand Breaks Is Bypassed by Dampening Tel1 or Rad53 Activity

41. P2.03b-063 Molecular Profiling in Advanced Non-Small-Cell Lung Cancer: Preliminary Data of an Italian Observational Prospective Study

42. DNA amount comparison between cytologic and histologic samples for epithelial growth factor receptor (EGFR) testing in non-small-cell lung cancer (NSCLC) patients: a single institution experience

43. Interplays between ATM/Tel1 and ATR/Mec1 in sensing and signaling DNA double-strand breaks

44. Molecular profiling in advanced non-small-cell lung cancer: preliminary data of the Italian observational prospective study

45. Intercalated chemotherapy and epidermal growth factor receptor inhibitors for patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis

46. G(1)/S and G(2)/M cyclin-dependent kinase activities commit cells to death in the absence of the S-phase checkpoint

47. Telomere uncapping at the crossroad between cell cycle arrest and carcinogenesis

Catalog

Books, media, physical & digital resources